David Krempa - Chief Business Officer at Eton Pharmaceuticals, Inc.

Issuer-level insider activity

Role
Chief Business Officer
Issuer ticker
ETON on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for David Krempa in Eton Pharmaceuticals, Inc.

Buys

Open market
Shares
Avg price
Total value

Sells

Open market
Shares
-100,000
Avg price
$32.30
Total value
-$3,229,923

Net

Past year
Shares
-100,000
Share %
-100%
Total value
-$3,229,923

Reported holdings for David Krempa in Eton Pharmaceuticals, Inc.

Form 4 holding Chief Business Officer

Eton Pharmaceuticals, Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
$206,527
Report date
12 Jul 2026
Price
$7.98
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Business Officer

Eton Pharmaceuticals, Inc.

Security class
Employee Stock Option (Right to Buy)
Shares / value
670,893
Estimated value
Report date
12 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for David Krempa in Eton Pharmaceuticals, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .